arrow
M

Martin Bæk Blond

copenhagen university hospital
H指数:15
被引数:1,348

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Impact of Albuminuria-Lowering Treatments on Cardiovascular Predictive Ceramides in Diabetes: Post Hoc Analysis of the ROTATE Trials

糖尿病中降低白蛋白尿治疗对心血管预测性鞘脂的影响:ROTATE试验的事后分析

2026-07-310
OAAI
Effects of exercise and exercise timing on energy intake and appetite control: a randomised crossover trial in people with overweight or obesity with and without type 2 diabetes

运动及运动时间对能量摄入和食欲控制的影响:一项针对有和无2型糖尿病的超重或肥胖人群的随机交叉试验

2026-07-010
OA
Effects of time-restricted eating on glycemic control and variability in individuals with overweight/obesity and prediabetes: A secondary analysis of the RESET randomized controlled trial

限时进食对超重/肥胖和糖尿病前期个体血糖控制和变异性的影响:RESET随机对照试验的二次分析

2026-04-210
PRE
Physical Fitness with Exercise and GLP-1 Receptor Agonist Treatment Alone or Combined After Diet-Induced Weight Loss: A Secondary Analysis of a Randomized Controlled Trial in Adults with Obesity

饮食引起的体重减轻后,单独或联合运动和GLP-1受体激动剂治疗的身体健康状况: 对肥胖成人的随机对照试验的二次分析

2026-01-240
OAAI
Exercise maintains LEAP2 levels after weight loss in females with obesity

运动在女性肥胖者体重减轻后维持LEAP2水平

2025-11-280
OAAI
Left ventricular ejection fraction reserve and its association with myocardial perfusion, coronary calcification, and strain in type 2 diabetes without overt cardiovascular disease

左心室射血分数储备及其与心肌灌注、冠状动脉钙化及应变在2型糖尿病合并无显性心血管疾病中的关联

2025-09-160
OAAI
Protocol for a 1-year randomised, controlled, parallel group, open-label trial on the effects and feasibility of time-restricted eating in individuals with type 2 diabetes- The Restricted Eating Time in the Treatment of Type 2 Diabetes (RESET2) trial
2025-01-110
OA
Effects of 3 months of 10-h per-day time-restricted eating and 3 months of follow-up on bodyweight and cardiometabolic health in Danish individuals at high risk of type 2 diabetes: the RESET single-centre, parallel , superiority, open-label, randomised controlled trial
2024-05-014
OA
Healthy weight loss maintenance with exercise, GLP-1 receptor agonist, or both combined followed by one year without treatment: a post-treatment analysis of a randomised placebo-controlled trial

通过运动,GLP-1受体激动剂或两者联合维持健康的体重减轻,随后一年不治疗: 一项随机安慰剂对照试验的治疗后分析

2024-03-0129
OAAI
Combination of exercise and GLP-1 receptor agonist treatment reduces severity of metabolic syndrome, abdominal obesity, and inflammation: a randomized controlled trial
2023-02-2537
OAAI
The GDF15-GFRAL pathway is dispensable for the effects of metformin on energy balance

GDF15-GFRAL途径对于二甲双胍对能量平衡的影响是必不可少的

2022-08-0124
OA
No effects of dapagliflozin, metformin or exercise on plasma glucagon concentrations in individuals with prediabetes: A post hoc analysis from the randomized controlled PRE-D trial
2020-11-188
OAAI
The effects of dapagliflozin, metformin or exercise on glycaemic variability in overweight or obese individuals with prediabetes (the PRE-D Trial): a multi-arm, randomised, controlled trial

达格列净、二甲双胍或运动对超重或肥胖的糖尿病前期患者血糖变异性的影响 (pre-d试验): 一项多组、随机、对照试验

2020-10-1627
OAAI